Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G R R Ricciardi

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Critical Reviews in Oncology/Hematology|August 16, 2017
Third generation EGFR TKIs in EGFR-mutated NSCLC: Where are we now and where are we goingA Russo, T Franchina, G R R Ricciardi, et al.
Journal of Cellular Physiology|February 9, 2011
Role of interleukin-23 circulating levels increase in resected colorectal cancer before and after chemotherapy: preliminary data and future perspectivesV Adamo, T Franchina, P L Minciullo, et al.
Critical Reviews in Oncology/Hematology|September 11, 2018
The changing scenario of 1A Russo, T Franchina, G R R Ricciardi, et al.
European Journal of Cancer (Oxford, England : 1990)|July 16, 2011
Management and treatment of triple-negative breast cancer patients from the NEMESI study: an Italian experienceV Adamo, G R R Ricciardi, S De Placido, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Critical Reviews in Oncology/Hematology|August 16, 2017
Third generation EGFR TKIs in EGFR-mutated NSCLC: Where are we now and where are we goingA Russo, T Franchina, G R R Ricciardi, et al.
Journal of Cellular Physiology|February 9, 2011
Role of interleukin-23 circulating levels increase in resected colorectal cancer before and after chemotherapy: preliminary data and future perspectivesV Adamo, T Franchina, P L Minciullo, et al.
Critical Reviews in Oncology/Hematology|September 11, 2018
The changing scenario of 1A Russo, T Franchina, G R R Ricciardi, et al.
European Journal of Cancer (Oxford, England : 1990)|July 16, 2011
Management and treatment of triple-negative breast cancer patients from the NEMESI study: an Italian experienceV Adamo, G R R Ricciardi, S De Placido, et al.
Pageof 1